Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Robbins

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Bulletin of the World Health Organization|February 6, 2004
Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccinesJohn B Robbins, Rachel Schneerson, Emil C Gotschlich, et al.
Infection and Immunity|November 22, 2005
Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in miceZhigang Jin, Gregory A Bohach, Joseph Shiloach, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2006
Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25Joanna Kubler-Kielb, Fathy Majadly, Yimin Wu, et al.
Vaccine|August 12, 2017
Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in miceNahid Farzam, Reut Ramon-Saraf, Yonit Banet-Levi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2011
Comparative long-term adverse effects elicited by invasive group B and C meningococcal infectionsMagnus Gottfredsson, Ingi K Reynisson, Ragnar F Ingvarsson, et al.
Clinical and Diagnostic Laboratory Immunology|January 11, 2003
Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannanJosephine Anne D Navoa, Suman Laal, Liise-Anne Pirofski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2003
Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccineRachel Schneerson, Joanna Kubler-Kielb, Teh-Yung Liu, et al.
Vaccine|April 23, 2003
Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzaeXin-Xing Gu, Susan F Rudy, Chiayung Chu, et al.
The Pediatric Infectious Disease Journal|May 3, 2012
Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood seraDaniel S Schmidt, Kathryn T Bieging, Patricia Gomez-de-León, et al.
The Pediatric Infectious Disease Journal|May 5, 2011
Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal diseaseFeng-Ying C Lin, Leonard E Weisman, Parvin Azimi, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Bulletin of the World Health Organization|February 6, 2004
Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccinesJohn B Robbins, Rachel Schneerson, Emil C Gotschlich, et al.
Infection and Immunity|November 22, 2005
Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in miceZhigang Jin, Gregory A Bohach, Joseph Shiloach, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2006
Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25Joanna Kubler-Kielb, Fathy Majadly, Yimin Wu, et al.
Vaccine|August 12, 2017
Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in miceNahid Farzam, Reut Ramon-Saraf, Yonit Banet-Levi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2011
Comparative long-term adverse effects elicited by invasive group B and C meningococcal infectionsMagnus Gottfredsson, Ingi K Reynisson, Ragnar F Ingvarsson, et al.
Clinical and Diagnostic Laboratory Immunology|January 11, 2003
Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannanJosephine Anne D Navoa, Suman Laal, Liise-Anne Pirofski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2003
Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccineRachel Schneerson, Joanna Kubler-Kielb, Teh-Yung Liu, et al.
Vaccine|April 23, 2003
Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzaeXin-Xing Gu, Susan F Rudy, Chiayung Chu, et al.
The Pediatric Infectious Disease Journal|May 3, 2012
Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood seraDaniel S Schmidt, Kathryn T Bieging, Patricia Gomez-de-León, et al.
The Pediatric Infectious Disease Journal|May 5, 2011
Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal diseaseFeng-Ying C Lin, Leonard E Weisman, Parvin Azimi, et al.
Pageof 6